Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 872076)

Published in Cancer Res on August 01, 1977

Authors

F P Noonan, W J Halliday, D R Wall, G J Clunie

Articles by these authors

What is the future of the hospital system? Med J Aust (1997) 2.72

Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med (1983) 2.26

The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci (2007) 1.90

Laparoscopic versus open appendectomy: prospective randomized trial. World J Surg (1996) 1.62

Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med (1998) 1.62

Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1995) 1.54

Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity. Photochem Photobiol (1981) 1.50

Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. Immunology (1981) 1.32

Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors. Int J Cancer (1972) 1.31

Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies. J Immunol (1984) 1.30

The safety and efficacy of laparoscopic live donor nephrectomy: a systematic review. Transplantation (2000) 1.28

Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens. J Immunol (1971) 1.27

Iatrogenic bile duct injury: the scourge of laparoscopic cholecystectomy. ANZ J Surg (2002) 1.27

Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide. Cell Immunol (1971) 1.26

An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet (1977) 1.26

Immunosuppression detected in pregnant mice by rosette inhibition test. Nature (1974) 1.25

Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery (1980) 1.24

Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond B Biol Sci (1976) 1.23

Restoration of renal function by arterial surgery. Lancet (1974) 1.21

Retained biliary calculi: removal by a simple non-operative technique. Ann Surg (1974) 1.20

The mechanism of tolerance in contact hypersensitivity to dinitrochlorobenzene in guinea-pigs. Clin Exp Immunol (1974) 1.20

Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16

Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma. Int J Cancer (1975) 1.15

Early pregnancy factor is immunosuppressive. Nature (1979) 1.09

Autotransplantation of the kidney in the treatment of renovascular hypertension. Surgery (1971) 1.08

Immunological reactivity associated with antigens in the intestinal tract of rats. J Pathol Bacteriol (1967) 1.05

Cell-mediated immunity and serum blocking factors in patients with chronic dermatophytic infections. Int Arch Allergy Appl Immunol (1974) 1.05

Immunological paralysis of mice with pneumococcal polysaccharide antigens. Bacteriol Rev (1971) 1.04

The safety of elective liver resection in a special unit. Aust N Z J Surg (1994) 1.02

Studies of contact hypersensitivity and tolerance in vivo and in vitro. I. Basic characteristics of the reactions and confirmation of an immune response in tolerant mice. Int Arch Allergy Appl Immunol (1978) 1.02

Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test. J Natl Cancer Inst (1974) 1.02

Acceleration of B16 melanoma growth in mice after blood transfusion. Surgery (1987) 1.01

Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test. Br J Cancer (1974) 1.01

Detection and separation of two serum factors responsible for depression of lymphocyte activity in pregnancy. Clin Exp Immunol (1978) 1.00

Hepatectomy for pyogenic liver abscess. HPB (Oxford) (2003) 1.00

Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. The role of urocanic acid. Clin Exp Immunol (1988) 0.98

Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leucocyte adherence inhibition test. Cell Immunol (1974) 0.97

The nature of piecemeal necrosis in chronic active hepatitis. Lancet (1979) 0.95

Kidney preservation for transportation. Function of 29 human-cadaver kidneys preserved with an intracellular perfusate. N Engl J Med (1971) 0.94

Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol (1983) 0.94

Intermittent haemodialysis: insertion and care of the silastic-teflon cannula. Br Med J (1967) 0.93

Splenectomy for anaemia in patients on regular haemodialysis. Lancet (1971) 0.93

Humoral and cellular responses of mice to a pneumococcal polysaccharide antigen. Circulating antibodies. Aust J Exp Biol Med Sci (1970) 0.92

A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer. Int J Cancer (1977) 0.92

Immune responses of mice to iodoacetate-treated Ehrlich ascites tumour cells. Br J Cancer (1967) 0.92

An integrated service for the treatment of irreversible renal failure. Med J Aust (1971) 0.91

Delayed hypersensitivity to chemically induced tumors in mice and correlation with an in vitro test. J Natl Cancer Inst (1969) 0.91

The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Lymphokine Cytokine Res (1991) 0.91

Routine use of indwelling ureteral stents in renal transplantation. J Urol (1993) 0.90

Anatomic resection for severe liver trauma. Surgery (1998) 0.90

Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss. Cell Immunol (1972) 0.90

Quantitation of anti-tumor cell-mediated immunity by a lymphokine-dependent reaction using small volumes of blood. Cell Immunol (1975) 0.90

Cellular origin of blocking factors from cultured spleen cells of tumor-bearing mice. Cell Immunol (1983) 0.89

Suppression of contact hypersensitivity by ultraviolet radiation: an experimental model. Springer Semin Immunopathol (1981) 0.88

Further characterization of the cells involved in leukocyte adherence inhibition with murine tumor extracts. Cell Immunol (1982) 0.88

Detection of early pregnancy in sheep by the rosette inhibition test. J Reprod Fertil (1979) 0.88

Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses. Aust N Z J Med (1972) 0.87

Circulating suppressor factors in mice subjected to ultraviolet irradiation and contact sensitization. Immunology (1986) 0.87

Cellular requirements for the suppression of leucocyte adherence inhibition reactions by serum factors from tumour-bearing mice. Immunology (1986) 0.87

Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer. J Natl Cancer Inst (1980) 0.86

An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer. Cancer Res (1977) 0.86

Review of keratinocyte culture techniques: problems of growing skin. Aust N Z J Surg (1989) 0.86

Renovascular hypertension: the place of renal autotransplantation. Br J Surg (1973) 0.86

Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect Immun (1992) 0.86

Immune suppression by ultraviolet radiation and its role in ultraviolet radiation induced carcinogenesis in mice. Australas J Dermatol (1985) 0.86

Genetic restriction of the serum factor mediating tolerance in trinitrochlorobenzene hypersensitivity. Cell Immunol (1980) 0.86

Biologically effective doses of sunlight for immune suppression at various latitudes and their relationship to changes in stratospheric ozone. Photochem Photobiol (1990) 0.86

The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85

Child-Pugh class, nutritional indicators and early liver transplant outcomes. Hepatogastroenterology (2001) 0.85

Electrocardiographic monitoring of cardiac transplants in mice. Cardiovasc Res (1988) 0.85

Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. I. Cell and serum activity detected by leukocyte adherence inhibition. J Natl Cancer Inst (1981) 0.84

Immunity and paralysis in mice. Serological and biological properties of two distinct antibodies to type III pneumococcal polysaccharide. Immunology (1970) 0.84

Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition. Br Med J (1974) 0.84

Genetic control of susceptibility to UV-induced immunosuppression by interacting quantitative trait loci. Genes Immun (2000) 0.83

The cellular mechanism of leukocyte adherence inhibition. J Immunol (1979) 0.83

Interactions between T and B lymphocytes and macrophages in the production of leukocyte adherence inhibition factor. Cell Immunol (1980) 0.83

Inhibition of whole blood antibody dependent cellular cytotoxicity by heat aggregated human IgG. J Immunol Methods (1981) 0.83

Suppression of contact hypersensitivity by short-term ultraviolet irradiation: I. Immunosuppression by serum from irradiated mice. Clin Exp Immunol (1988) 0.83

Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. II. Nature of blocking and unblocking factors in serum. J Natl Cancer Inst (1981) 0.83

Antilymphocyte serum: studies of the specificity of the rosette-inhibiting antibody in rabbit anti-mouse ALS. Aust J Exp Biol Med Sci (1976) 0.83

Historical background and aspects of the mechanism of leukocyte adherence inhibition. Cancer Res (1979) 0.82

Humoral and cellular responses of mice to a pneumococcal polysaccharide antigen. Plaques and paralysis, in vivo and in vitro. Aust J Exp Biol Med Sci (1970) 0.82

A single dose of UV radiation suppresses delayed type hypersensitivity responses to alloantigens and prolongs heart allograft survival in mice. Immunol Cell Biol (1989) 0.81

Hyperparathyroid crisis. Br J Surg (1967) 0.81

Correlation between ADCC resistance to in vitro steroid and renal allograft failure. Transplant Proc (1981) 0.81

Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci U S A (1985) 0.81

Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses. Transplant Proc (1989) 0.80

Abdominal hernias complicating continuous ambulatory peritoneal dialysis. Am J Nephrol (1986) 0.80

Kidney transplantation from living related donors: a 19-year experience. Med J Aust (1993) 0.80

Exchange of cadaveric kidneys for transplantation in Australia and New Zealand. Aust N Z J Med (1979) 0.79

Apoptosis as the mode of cell death in antibody-dependent lymphocytotoxicity. J Cell Sci (1985) 0.79

The rosette inhibition test: technical considerations. Transplantation (1972) 0.79

A two-chain tumour-related suppressor factor specific for a sequence antigen. Immunol Lett (1984) 0.79

Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors. J Natl Cancer Inst (1982) 0.79

Results of surgical treatment of renovascular hypertension. Med J Aust (1975) 0.79